Published in Gut on July 01, 2001
Fibrolamellar carcinoma: 2012 update. Scientifica (Cairo) (2012) 1.06
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients. Oncotarget (2015) 0.86
Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features. Epigenetics (2015) 0.78
Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res (1990) 23.96
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (1993) 12.74
Genomic fingerprints produced by PCR with consensus tRNA gene primers. Nucleic Acids Res (1991) 5.70
Genomic fingerprinting by arbitrarily primed polymerase chain reaction resolves Borrelia burgdorferi into three distinct phyletic groups. Int J Syst Bacteriol (1992) 4.16
Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer (1980) 3.82
Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet (1986) 2.07
Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res (1998) 1.74
Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc Natl Acad Sci U S A (1992) 1.74
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J (Clin Res Ed) (1982) 1.55
Genomic heterogeneity in synchronous hepatocellular carcinomas. Gut (1999) 1.44
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology (1997) 1.36
Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet (1984) 1.34
Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res (1996) 1.33
Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol (1988) 1.30
Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. Oncogene (1994) 1.13
Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer (1991) 1.10
The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia. Cancer (1987) 1.06
p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br J Cancer (1998) 1.05
Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg (1986) 0.98
Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas. Int J Cancer (1999) 0.97
Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res (1998) 0.93
Fibrolamellar carcinoma of liver: a primary malignant oncocytic carcinoid? Ultrastruct Pathol (1986) 0.92
Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report. Am J Gastroenterol (1998) 0.88
Expression of the neurotensin gene in fetal human liver and fibrolamellar carcinoma. Ann Surg (1994) 0.85
Infrequent chromosome allele loss in fibrolamellar carcinoma. Br J Cancer (1993) 0.83
Identification of allelic loss on chromosome arm 6p in human astrocytomas by arbitrarily primed polymerase chain reaction. Genes Chromosomes Cancer (1998) 0.82
Incidental finding of a hepatic lesion: differential diagnostic problems for fibrolamellar hepatic carcinoma. J Nucl Med (1994) 0.81
DNA ploidy of fibrolamellar hepatocellular carcinoma by image analysis. Hum Pathol (1994) 0.80
Comparison of genetic changes in frozen biopsies and microdissected archival material from the same colorectal liver metastases. Diagn Mol Pathol (1997) 0.79
Evolution of genetic abnormalities in hepatocellular carcinomas demonstrated by DNA fingerprinting. J Pathol (1999) 0.79
Cloning of size-selected human immunoglobulin heavy-chain rearrangements from third complementarity-determining region fingerprint profiles. Biotechniques (1996) 0.77
Estimating the support of a high-dimensional distribution. Neural Comput (2001) 5.98
Torsion of the testis and allied conditions. Br J Surg (1976) 4.04
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01
Effect of luminal growth factor preservation on intestinal growth. Lancet (1993) 3.25
Viability of exfoliated colorectal carcinoma cells. Br J Surg (1984) 3.11
Appendicitis in external herniae. Ann R Coll Surg Engl (1982) 2.99
Intestinal adaptation (first of two parts). Structural, functional and cytokinetic changes. N Engl J Med (1978) 2.76
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch (2001) 2.73
Acute pancreatitis: a lethal disease of increasing incidence. Gut (1985) 2.68
Appendicitis and mimicking conditions. A prospective study. Lancet (1975) 2.60
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer (1991) 2.52
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Survival of 727 patients with single carcinomas of the large bowel. Dis Colon Rectum (1984) 2.47
Systematic review of randomized controlled trials on the effectiveness of virtual reality training for laparoscopic surgery. Br J Surg (2008) 2.43
Pancreatic tissue and ductal pressures in chronic pancreatitis. Br J Surg (1991) 2.40
Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg (2010) 2.38
Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene (2006) 2.36
A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology (1993) 2.34
Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. Oncogene (2007) 2.14
Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13
Early assessment of severity in acute pancreatitis. Gut (1984) 2.11
Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ (2008) 2.03
Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. N Engl J Med (1985) 1.97
p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet (1991) 1.95
The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci (2000) 1.93
The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma. Ann R Coll Surg Engl (1984) 1.91
Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg (1992) 1.91
Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg (2010) 1.88
Gene therapy for cancer. Lancet (1992) 1.81
Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol (1987) 1.80
Splenectomy: indications, hazards and alternatives. Br J Surg (1984) 1.75
Survival in acute obstructing colorectal carcinoma. Dis Colon Rectum (1984) 1.72
Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse. Gut (1985) 1.68
Pancreatic cancer genetics. Pancreatology (2001) 1.68
Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene (2001) 1.68
The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res (1992) 1.64
Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas. J Pathol (1992) 1.63
Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene (1992) 1.62
Multidisciplinary approach to biliary complications of laparoscopic cholecystectomy. Br J Surg (1998) 1.59
Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol (1991) 1.58
The clinical syndrome of mammary duct ectasia. Br J Surg (1982) 1.57
Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model. Br J Surg (2000) 1.56
Distal pancreatectomy with and without splenectomy. Br J Surg (1991) 1.53
Single-loop biliary and gastric bypass for irresectable pancreatic carcinoma. Br J Surg (1993) 1.53
Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg (2007) 1.52
Modern management of pancreatic pseudocysts. Br J Surg (1993) 1.51
Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol (1994) 1.51
Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol (1996) 1.49
Enhanced intra-anastomotic healing by operative lavage with nutrient solutions in experimental left-sided colonic obstruction. Br J Surg (1995) 1.48
Koch's postulates revisited. J Pathol (1991) 1.46
Study of common bile duct exploration and endoscopic sphincterotomy in a consecutive series of 438 patients. Br J Surg (1987) 1.45
Genomic heterogeneity in synchronous hepatocellular carcinomas. Gut (1999) 1.44
Anastomotic recurrence in large bowel cancer. Br J Surg (1987) 1.42
Comparison of manual data coding errors in two hospitals. J Clin Pathol (1986) 1.42
Primary squamous carcinoma of liver: presentation as liver abscess. Indian J Gastroenterol (1998) 1.42
Cholecystokinin infusion: assessing a rather provocative test. Gut (1998) 1.41
The use of DNA viruses as vectors for gene therapy. Gene Ther (1994) 1.41
Meta-analysis of randomized controlled trials on the safety and effectiveness of day-case laparoscopic cholecystectomy. Br J Surg (2008) 1.40
Intestinal adaptation (second of two parts). Mechanisms of control. N Engl J Med (1978) 1.40
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res (1995) 1.40
Peritoneal seeding of pancreatic head carcinoma following percutaneous transhepatic drainage and stenting. Br J Surg (1997) 1.40
Proliferative and metastatic potential of exfoliated colorectal cancer cells. J Natl Cancer Inst (1986) 1.39
The c-erb B-2 proto-oncogene in human pancreatic cancer. J Pathol (1990) 1.39
Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol (1993) 1.39
The management of peptic oesophageal stricture. Br J Surg (1975) 1.39
Hydrallazine-induced SLE-like syndrome presenting as a leg ulcer. Br Med J (1979) 1.38
Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg (1995) 1.38
Adenocarcinoma and lymphoma of the small intestine. Distribution and etiologic associations. Ann Surg (1983) 1.36
Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer (2001) 1.36
Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet (1985) 1.34
Promotion of azoxymethane-induced colonic neoplasia by resection of the proximal small bowel. Cancer Res (1978) 1.31
Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol (1997) 1.29
Humoral stimulation of cell proliferation in small bowel after transection and resection in rats. Gastroenterology (1978) 1.28
Testicular torsion in Bristol: a 25-year review. Br J Surg (1988) 1.26
Contrasting effects of subtotal enteric bypass, enterectomy, and colectomy on azoxymethane-induced intestinal carcinogenesis. Cancer Res (1980) 1.26
Endoscopic extraction of bile duct stones: management related to stone size. Gut (1993) 1.24
Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin. J Pathol (1998) 1.24
Peculiarities of mucinous colorectal carcinoma. Br J Surg (1985) 1.24
Prevention of venous thromboembolism in cancer patients. Semin Thromb Hemost (1999) 1.22
High frequency of K-ras mutations in sporadic colorectal adenomas. Gut (1993) 1.22
Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours. Oncogene (1991) 1.20
Biliary motility. Gut (1990) 1.20
Total pancreatectomy for chronic pancreatitis. Br J Surg (1987) 1.19
Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet (1995) 1.19
Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet (1994) 1.18
Management of colorectal liver metastases. Colorectal Dis (2003) 1.17
Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Br J Cancer (1996) 1.16
Intestinal adaptation and experimental carcinogenesis after partial colectomy. Increased tumour yields are confined to the anastomosis. Gut (1982) 1.16
Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut (2006) 1.15
Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer. Oncogene (2007) 1.15
Colostomy closure promotes cell proliferation and dimethylhydrazine-induced carcinogenesis in rat distal colon. Gastroenterology (1981) 1.15
Surgical treatment of primary duodenal carcinoma: a personal series. Br J Surg (1994) 1.14
In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg (1998) 1.14
Experimental pancreatic hyperplasia and neoplasia: effects of dietary and surgical manipulation. Br J Cancer (1993) 1.14
On-table pancreatography: importance in planning operative strategy. Br J Surg (1990) 1.13
Liver tumours due to endometriosis and endometrial stromal sarcoma. HPB (Oxford) (2002) 1.13